America Great Health(AAGH)
$0.00-0.00 (-66.67%)
AAGH
America Great Health financials statements
$0.00
At close:-0.00 (-66.67%)
America Great Health (AAGH) Ratios
31 Followers
America Great Health Ratios
AAGH's free cash flow for Q3 2026 was $1.74K. For the 2026 fiscal year, AAGH's free cash flow was increased by $0.00 and operating cash flow was $1.74K. See a summary of the company’s cash flow.
| Ratios | Jun 25 | Jun 24 | Jun 23 | Jun 22 | Jun 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.06 | 0.06 | 0.06 | 0.07 | 1.12 |
| Quick Ratio | 0.02 | 0.04 | 0.02 | 0.03 | 1.10 |
| Cash Ratio | 0.01 | 0.02 | 0.02 | 0.02 | 0.92 |
| Solvency Ratio | -0.12 | -0.21 | -0.16 | -1.16 | -0.25 |
| Operating Cash Flow Ratio | -0.09 | -0.17 | -0.24 | -0.54 | -0.76 |
| Short-Term Operating Cash Flow Coverage | -0.54 | -1.01 | -1.07 | -8.05 | -1.02 |
| Net Current Asset Value | $ -5.81M | $ -5.41M | $ -4.65M | $ -4.00M | $ -607.42K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 9.43 | 7.68 | 6.25 | 3.90 | 1.66 |
| Debt-to-Equity Ratio | -0.50 | -0.47 | -0.42 | -0.34 | -2.21 |
| Debt-to-Capital Ratio | -0.98 | -0.90 | -0.72 | -0.53 | 1.83 |
| Long-Term Debt-to-Capital Ratio | -0.63 | -0.54 | -0.52 | -0.37 | 5.09 |
| Financial Leverage Ratio | -0.05 | -0.06 | -0.07 | -0.09 | -1.33 |
| Debt Service Coverage Ratio | -1.36 | -0.73 | -0.44 | -12.61 | -0.72 |
| Interest Coverage Ratio | 1.13 | -1.76 | -1.54 | -24.80 | -12.15 |
| Debt to Market Cap | 0.45 | 0.39 | 0.08 | 0.05 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | -7.31 | -3.16 | -4.06 | -0.26 | -2.56 |
| Profitability Margins | |||||
| Gross Profit Margin | 86.57% | 57.61% | 82.52% | -1417.90% | 26.24% |
| EBIT Margin | -97.74% | -265.60% | -223.99% | -4523.76% | -127.26% |
| EBITDA Margin | -97.75% | -260.58% | -218.93% | -4518.12% | -127.26% |
| Operating Profit Margin | -97.75% | -265.62% | -241.13% | -4523.83% | -124.47% |
| Pretax Profit Margin | -184.11% | -416.18% | -380.47% | -4706.19% | -137.50% |
| Net Profit Margin | -184.11% | -414.22% | -372.68% | -4650.02% | -137.50% |
| Continuous Operations Profit Margin | -184.11% | -416.18% | -380.47% | -4706.19% | -137.50% |
| Net Income Per EBT | 100.00% | 99.53% | 97.95% | 98.81% | 100.00% |
| EBT Per EBIT | 188.35% | 156.68% | 157.79% | 104.03% | 110.47% |
| Return on Assets (ROA) | -238.97% | -377.33% | -254.55% | -1447.64% | -43.19% |
| Return on Equity (ROE) | 12.56% | 23.33% | 17.11% | 128.00% | 57.51% |
| Return on Capital Employed (ROCE) | 10.88% | 23.94% | 17.64% | 195.52% | -127.79% |
| Return on Invested Capital (ROIC) | 13.33% | 29.63% | 24.08% | 218.52% | -43.11% |
| Return on Tangible Assets | -238.97% | -377.33% | -254.55% | -1447.64% | -43.19% |
| Earnings Yield | -11.37% | -19.26% | -2.78% | -19.23% | -0.08% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 5.35 | 0.00 | 114.00 | 3.20 |
| Payables Turnover | 0.04 | 0.09 | 0.02 | 1.10 | 2.52 |
| Inventory Turnover | 0.32 | 1.50 | 0.33 | 13.69 | 18.39 |
| Fixed Asset Turnover | 7.35 | 3.42 | 2.05 | 0.89 | 1.40 |
| Asset Turnover | 1.30 | 0.91 | 0.68 | 0.31 | 0.31 |
| Working Capital Turnover Ratio | -0.11 | -0.09 | -0.07 | -0.08 | -2.39 |
| Cash Conversion Cycle | -9188.27 | -3884.20 | -13715.32 | -300.45 | -10.80 |
| Days of Sales Outstanding | 0.00 | 68.25 | 0.00 | 3.20 | 114.04 |
| Days of Inventory Outstanding | 1142.06 | 242.93 | 1107.17 | 26.67 | 19.85 |
| Days of Payables Outstanding | 10330.33 | 4195.38 | 14822.49 | 330.32 | 144.69 |
| Operating Cycle | 1142.06 | 311.18 | 1107.17 | 29.87 | 133.89 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | -16.95 | -87.82 | -25.98 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | -16.95 | -87.82 | -25.98 |
| Operating Cash Flow Coverage Ratio | -0.12 | -0.25 | -0.40 | -1.13 | -0.32 |
| Operating Cash Flow to Sales Ratio | -0.85 | -2.09 | -3.69 | -14.14 | -1.68 |
| Free Cash Flow Yield | -5.25% | -9.71% | -2.91% | -5.91% | -0.10% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -8.79 | -5.19 | -36.01 | -5.20 | -1271.57 |
| Price-to-Sales (P/S) Ratio | 16.19 | 21.51 | 134.22 | 241.84 | 1748.45 |
| Price-to-Book (P/B) Ratio | -1.10 | -1.21 | -6.16 | -6.66 | -731.30 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -19.06 | -10.29 | -34.39 | -16.91 | -1000.61 |
| Price-to-Operating Cash Flow Ratio | -19.06 | -10.29 | -36.42 | -17.10 | -1039.12 |
| Price-to-Earnings Growth (PEG) Ratio | 0.09 | 0.00 | 0.36 | 0.00 | 0.00 |
| Enterprise Value Multiple | -23.88 | -11.42 | -65.37 | -5.62 | -1376.48 |
| Enterprise Value | 9.14M | 8.77M | 29.24M | 26.56M | 342.76M |
| EV to EBITDA | -23.88 | -11.42 | -65.37 | -5.62 | -1376.48 |
| EV to Sales | 23.34 | 29.75 | 143.11 | 253.76 | 1751.70 |
| EV to Free Cash Flow | -27.47 | -14.24 | -36.67 | -17.74 | -1002.47 |
| EV to Operating Cash Flow | -27.47 | -14.24 | -38.83 | -17.94 | -1041.05 |
| Tangible Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Shareholders’ Equity Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Tax Burden | 1.00 | 1.00 | 0.98 | 0.99 | 1.00 |
| Interest Burden | 1.88 | 1.57 | 1.70 | 1.04 | 1.08 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 1.84 | 2.91 | 3.22 | 30.23 | 1.51 |
| Stock-Based Compensation to Revenue | 0.00 | 0.42 | 0.32 | 13.01 | 0.01 |
| Income Quality | 0.46 | 0.50 | 0.99 | 0.30 | 1.22 |
Currency in USD
